OverviewChartNewsTraderScreen

DZ Bank Discount Zert PFE 27.06.2.../  DE000DJ5H829  /

EUWAX
2025-01-02  8:22:36 AM Chg.+0.12 Bid12:06:42 PM Ask12:06:42 PM Underlying Strike price Expiration date Option type
23.79EUR +0.51% 23.93
Bid Size: 750		 -
Ask Size: -		 Pfizer Inc - USD 2025-06-27 Call
TeleTrader 2024-12-17 Pfizer projects 2025 revenue to reach up to $64B
TeleTrader 2024-12-05 Trump allegedly hosted Pfizer, Eli Lilly execs at Mar-a-Lago
TeleTrader 2024-11-20 Pfizer names new chief scientific officer
TeleTrader 2024-10-29 Pfizer's Q3 revenue jumps 31% to $17.7 billion
TeleTrader 2024-10-07 Starboard Value allegedly takes $1B stake in Pfizer
TeleTrader 2024-09-14 Pfizer reports positive data from experimental drug study
GlobeNewswire 2024-09-03 Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidat...
TeleTrader 2024-08-27 Pfizer launches digital platform to 'simplify' healthcare access
TeleTrader 2024-08-22 FDA okays Moderna, Pfizer updated vaccines
GlobeNewswire 2024-08-22 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 2024-08-16 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
TeleTrader 2024-07-30 Pfizer's Q2 revenue rises by 2% to $13.3B
GlobeNewswire 2024-07-17 Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion ...
TeleTrader 2024-07-11 Pfizer advances once-daily version of weight loss pill
TeleTrader 2024-07-09 Pfizer's chief scientific officer to leave after 15 years
GlobeNewswire 2024-06-27 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 2024-06-05 Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Co...
GlobeNewswire 2024-06-03 Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire 2024-05-16 Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...
GlobeNewswire 2024-05-09 Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medic...
TeleTrader 2024-05-01 Pfizer's Q1 revenue drops 20% to $14.9 billion
GlobeNewswire 2024-04-30 TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervica...
GlobeNewswire 2024-03-22 Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous ...
GlobeNewswire 2024-03-20 Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire 2024-03-07 BNTX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel B...